Clinical trial

Evaluation of the Efficacy of Ru-Yi-Jin-Huang-Saan on Colles' Fracture ---a Randomized, Double-blind, Placebo-controlled Trial

Name
RYJHS
Description
The purpose of this study is to assess the efficacy and safety of Ru-Yi-Jin-Huang-Saan for the treatment of Colles' fracture.
Trial arms
Trial start
2023-05-01
Estimated PCD
2024-05-31
Trial end
2024-06-30
Status
Recruiting
Phase
Early phase I
Treatment
Ru Yi Jin Huang Powder
Each patch contains 13g Ru Yi Jin Huang Powder and 10c.c. water.
Arms:
Ru-Yi-Jin-Huang-Saan
Other names:
golden patch
Placebo
Each patch contains 13g starch and 10c.c. water.
Arms:
Placebo
Other names:
starch
Size
100
Primary endpoint
Change from Baseline in Patient-Rated Wrist Evaluation(PRWE) scale at Day 6
Baseline and Day 6
Eligibility criteria
Inclusion Criteria: 1. People who are over 20 years old and have no lack of mental ability can understand the content of the experiment and are willing to participate in it. 2. Patients with Colles' fracture receive surgical fixation(ORIF). Exclusion Criteria: 1. People are unable to cooperate with experiments and fill out questionnaires. 2. Patients have wounds on the back of their wrists. 3. Patients are allergic to traditional Chinese medicine for external applications or have used other traditional Chinese medicine for external applications. 4. Patients have cancer, stroke, and systemic diseases such as severe anemia, thyroid disease, uncontrolled diabetes, etc. 5. Pregnant woman.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2023-06-06

1 organization

1 product

1 drug

1 indication

Indication
Colles fracture